• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗年龄相关性黄斑变性的患病率及其危险因素:一项系统评价和荟萃分析研究

Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study.

作者信息

Panahi Parsa, Kabir Ali, Falavarjani Khalil Ghasemi

机构信息

Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran.

Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.

出版信息

J Curr Ophthalmol. 2024 Aug 10;35(4):305-312. doi: 10.4103/joco.joco_40_23. eCollection 2023 Oct-Dec.

DOI:10.4103/joco.joco_40_23
PMID:39281400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11392294/
Abstract

PURPOSE

To estimate the prevalence of age-related macular degeneration (AMD) and determine its risk factors in Iran.

METHODS

A comprehensive electronic search was conducted in PubMed, Scopus, Web of Science, and Google Scholar, with no restrictions on time or language of publication. Eleven studies meeting the eligibility criteria were included. Six studies with a total sample size of 9930 were included in the meta-analysis to calculate the overall prevalence of AMD in Iran. Meta-analysis was performed using Stata/MP version 15.0. Risk of bias assessment was carried out based on the Newcastle-Ottawa Scale.

RESULTS

All participants in the studies were over 40 years old. The pooled prevalence of AMD was estimated to be 9.9% (95% confidence interval [CI]: 6.3%-13.5%). After accounting for publication bias, this estimated decreased to 6.4% (95% CI: 4%-10.2%). Smoking (odds ratio [OR]: 1.781; 95% CI: 1.152-2.756), hypertension (HTN) (OR: 1.512; 95% CI: 1.119-2.044), diabetes mellitus (DM) (OR: 1.545; 95% CI: 1.088-2.194), and hyperlipidemia (OR: 1.512; 95% CI: 1.055-2.165) were identified as AMD risk factors.

CONCLUSION

Based on the results of the present review, the prevalence of AMD in the Iranian population over 40 years of age is estimated to be 6.4%, and having a history of smoking, HTN, DM, and hyperlipidemia are identified as risk factors of AMD in Iran. Further original studies are needed to draw more accurate conclusions.

摘要

目的

评估伊朗年龄相关性黄斑变性(AMD)的患病率并确定其危险因素。

方法

在PubMed、Scopus、Web of Science和谷歌学术中进行全面的电子检索,对发表时间和语言均无限制。纳入了11项符合纳入标准的研究。六项总样本量为9930的研究被纳入荟萃分析,以计算伊朗AMD的总体患病率。使用Stata/MP 15.0版本进行荟萃分析。基于纽卡斯尔-渥太华量表进行偏倚风险评估。

结果

研究中的所有参与者均年龄超过40岁。AMD的合并患病率估计为9.9%(95%置信区间[CI]:6.3%-13.5%)。在考虑发表偏倚后,该估计值降至6.4%(95%CI:4%-10.2%)。吸烟(比值比[OR]:1.781;95%CI:1.152-2.756)、高血压(HTN)(OR:1.512;95%CI:1.119-2.044)、糖尿病(DM)(OR:1.545;95%CI:1.088-2.194)和高脂血症(OR:1.512;95%CI:1.055-2.165)被确定为AMD的危险因素。

结论

基于本综述的结果,估计伊朗40岁以上人群中AMD的患病率为6.4%,并且吸烟史、HTN、DM和高脂血症被确定为伊朗AMD的危险因素。需要进一步的原始研究以得出更准确的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11392294/528258f92109/JCO-35-305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11392294/8c693ac3626a/JCO-35-305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11392294/528258f92109/JCO-35-305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11392294/8c693ac3626a/JCO-35-305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11392294/528258f92109/JCO-35-305-g002.jpg

相似文献

1
Age-Related Macular Degeneration Prevalence and its Risk Factors in Iran: A Systematic Review and Meta-Analysis Study.伊朗年龄相关性黄斑变性的患病率及其危险因素:一项系统评价和荟萃分析研究
J Curr Ophthalmol. 2024 Aug 10;35(4):305-312. doi: 10.4103/joco.joco_40_23. eCollection 2023 Oct-Dec.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A Population-based Study on the Prevalence and Associated Factors of Age-related Macular Degeneration in Northern Iran .一项基于人群的伊朗北部年龄相关性黄斑变性患病率及相关因素的研究。
Ophthalmic Epidemiol. 2020 Jun;27(3):209-218. doi: 10.1080/09286586.2020.1716379. Epub 2020 Jan 21.
4
Prevalence of age-related macular degeneration in Iran and its projections through 2050: a systematic review and meta-analysis.伊朗年龄相关性黄斑变性的患病率及其到 2050 年的预测:系统评价和荟萃分析。
BMC Ophthalmol. 2023 Nov 25;23(1):484. doi: 10.1186/s12886-023-03218-3.
5
Prevalence of age-related macular degeneration among the elderly.老年人年龄相关性黄斑变性的患病率。
Caspian J Intern Med. 2015 Summer;6(3):141-7.
6
Protocol of global incidence and progression of age-related macular degeneration: A systematic review.年龄相关性黄斑变性的全球发病率及进展情况:一项系统评价方案
Medicine (Baltimore). 2019 Mar;98(10):e14645. doi: 10.1097/MD.0000000000014645.
7
Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018.伊朗高血压患病率:2004 - 2018年已发表研究的荟萃分析。
Curr Hypertens Rev. 2019;15(2):113-122. doi: 10.2174/1573402115666190118142818.
8
Prevalence and risk factors of type-2 diabetes mellitus in Ethiopia: systematic review and meta-analysis.在埃塞俄比亚,2 型糖尿病的患病率及危险因素:系统评价与荟萃分析。
Sci Rep. 2021 Nov 5;11(1):21733. doi: 10.1038/s41598-021-01256-9.
9
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
10
Prevalence and risk factors of hypertension among Hui population in China: A systematic review and meta-analysis based on 30,565 study participants.中国回族人群高血压的患病率及危险因素:基于30565名研究参与者的系统评价和荟萃分析
Medicine (Baltimore). 2021 May 7;100(18):e25192. doi: 10.1097/MD.0000000000025192.

引用本文的文献

1
Advances in materials science for ocular diseases induced by cardiovascular risk factors.心血管危险因素所致眼部疾病的材料科学进展
Front Bioeng Biotechnol. 2025 Jun 27;13:1618232. doi: 10.3389/fbioe.2025.1618232. eCollection 2025.

本文引用的文献

1
Thyroid Dysfunction as a Modifiable Risk Factor for Wet Type Age-Related Macular Degeneration: A Case-Control Study.甲状腺功能障碍作为湿性年龄相关性黄斑变性的可改变风险因素:一项病例对照研究
J Curr Ophthalmol. 2022 Jan 6;33(4):449-452. doi: 10.4103/joco.joco_174_20. eCollection 2021 Oct-Dec.
2
Dyslipidemia in age-related macular degeneration.年龄相关性黄斑变性中的血脂异常。
Eye (Lond). 2022 Feb;36(2):312-318. doi: 10.1038/s41433-021-01780-y. Epub 2022 Jan 11.
3
Global Incidence, Progression, and Risk Factors of Age-Related Macular Degeneration and Projection of Disease Statistics in 30 Years: A Modeling Study.
全球年龄相关性黄斑变性的发病率、进展和危险因素以及 30 年内疾病统计数据的预测:一项建模研究。
Gerontology. 2022;68(7):721-735. doi: 10.1159/000518822. Epub 2021 Sep 21.
4
MOOSE Reporting Guidelines for Meta-analyses of Observational Studies.观察性研究元分析的MOOSE报告指南。
JAMA Surg. 2021 Aug 1;156(8):787-788. doi: 10.1001/jamasurg.2021.0522.
5
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study.2020 年失明和视力障碍的原因及 30 多年来的趋势,以及与 VISION 2020:看见的权利相关的可避免盲的患病率:全球疾病负担研究的分析。
Lancet Glob Health. 2021 Feb;9(2):e144-e160. doi: 10.1016/S2214-109X(20)30489-7. Epub 2020 Dec 1.
6
Regional differences in the global burden of age-related macular degeneration.与年龄相关的黄斑变性的全球负担存在地域差异。
BMC Public Health. 2020 Mar 30;20(1):410. doi: 10.1186/s12889-020-8445-y.
7
A Population-based Study on the Prevalence and Associated Factors of Age-related Macular Degeneration in Northern Iran .一项基于人群的伊朗北部年龄相关性黄斑变性患病率及相关因素的研究。
Ophthalmic Epidemiol. 2020 Jun;27(3):209-218. doi: 10.1080/09286586.2020.1716379. Epub 2020 Jan 21.
8
Age-related macular degeneration.年龄相关性黄斑变性。
Lancet. 2018 Sep 29;392(10153):1147-1159. doi: 10.1016/S0140-6736(18)31550-2.
9
Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections.2015 年北非和中东视力丧失的患病率和病因:规模、时间趋势和预测。
Br J Ophthalmol. 2019 Jul;103(7):863-870. doi: 10.1136/bjophthalmol-2018-312068. Epub 2018 Sep 12.
10
Prevalence and Major Causes of Visual Impairment in Iranian Adults: A Systematic Review.伊朗成年人视力障碍的患病率及主要原因:一项系统综述
Middle East Afr J Ophthalmol. 2017 Jul-Sep;24(3):148-155. doi: 10.4103/meajo.MEAJO_168_16.